Q3 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: Sonnet BioTherapeutics(SONN) the EBIT is -3.806 M (-7.87%);the EPS is -0.952 (+82.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B7.87%
----
----
EPS
-0.952282.90%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf